March 3, 2015

Although an approval pathway for biosimilars has been available since the Affordable Care Act passed in 2010, the U.S. has yet to see the FDA approve a drug through this process. But the agency has been working with multiple companies that are hoping to finally gain approval for and launch these products, potentially increasing price competition of various biologics. And with an increasing

February 19, 2015

FREE Webinar: March 19, 2015 Medical Pharmacy Trend Report: Discover Your Hidden Specialty Drug Spend

Hosted March 19, 2015

Join us for this complimentary webinar as leaders from Magellan Rx discuss key ﬁndings from Magellan Rx Management’s 2014 Medical Pharmacy Trend Report: The industry’s only source for key trends and statistics on one of the nation’s biggest drivers of specialty spend, medical injectables.

Did you know specialty drug spend makes up over a quarter of total drug spend, half of which is attributed to medical pharmacy? The report shows that specialty drug management across the pharmacy and medical benefit is more important than ever. Do you have the right tools and information to manage this spend?

Specialty drug trends that are driving up costs
Uncovering the hidden costs of specialty drugs paid under the medical benefit
Effective and proven solutions for managing costs
Valuable intelligence from payor and health plan data

January 14, 2015

February 18, 2015 Webinar – Anthem’s Cancer Care Quality Program: A Blueprint to Improve Care and Reduce Costs

Recorded February 18, 2015

Learn about how Anthem has successfully implemented the Cancer Care Quality Program.

To make sure cancer patients are getting the most appropriate evidence-based care that is still cost-effective, some payers have turned to the use of pathways, which set forth certain treatment options and provider payment arrangements.

January 14, 2015

February 12, 2015 Webinar – PBM Contracts: Innovative Strategies to Improve Your Plan’s Bottom Line

Recorded February 12, 2015

Learn about innovative PBM contracting strategies for health plans.

As pharmacy benefit designs and drug pricing methodologies become more complex, insurers and plan sponsors spend more of their time bidding out PBM contracts and assessing potential partners. But long-term partnerships between PBMs and health plans are difficult to develop and maintain as PBM consolidation continues, drug prices continually change, “pass-through” pricing grows more complex, and the array of pharmacy network options available to plans and patients increases. How can health plans evaluate whether they have a competitive PBM deal today

December 21, 2014

January 27, 2015 Webinar – Offsetting the Spikes in Generic Drug Prices: Health Plan/PBM Strategies

Recorded January 27, 2015

Learn strategies for minimizing the impact of generic drug price inflation.

Sudden increases and fluctuations in the retail prices of generic pharmaceuticals, which now account for 86% of prescription drugs dispensed in the U.S., have become a chief concern for health plans, employers and PBMs that were hoping to maximize generic opportunities made possible by the ongoing patent cliff. While some generic outlier drugs have skyrocketed by more 1,000% in price, more than half of all generic drugs have experienced price increases in the last year, putting the overall inflationary trend in line with price increases of brand-name drugs.

May 15, 2014

FREE Webinar: June 19, 2014 Medical Pharmacy – The Future of Pharmacy Benefit Management

The Magellan Rx Management 2013 Medical Pharmacy Trend Report is the nation’s only comprehensive source for monitoring key trends and statistics related to high-cost injectable drugs paid under the medical benefit.

June 19 join us for this complimentary webinar and hear Mostafa Kamal, Senior Vice President and General Manager, Specialty Pharmacy, and Kristen Reimers, Director, Clinical Drug Programs, discuss the report’s key findings.

Specialty trends and effective cost management solutions
Hidden costs of specialty drugs paid under the medical benefit
Site of service threat that can’t be ignored
Intelligence from payor and health plan data

March 14, 2014

April 29, 2014 Webinar – How to Improve Drug-Related Star Ratings: Winning Strategies for MA-PD and PDP Plans

Get answers to your questions on how to develop a strong drug-related star-ratings strategy and stay ahead of new CMS program requirements

As CMS enhances and modifies its star-ratings program each year, it raises the bar for Medicare plans to deliver ever-higher quality care. Since the pharmacy benefit is the primary objective of Prescription Drug Plans (PDPs) and a critical component of Medicare Advantage Prescription Drug (MA-PD) plans, the pressure is on pharmacy departments to deliver winning strategies to improve health plan star ratings.
Continue Reading

December 16, 2013

Jan. 28, 2014 Webinar – PBM Contracts: How to Use Audits and Market Checks to Improve Your Bottom Line

*Find out what two experienced pharmacy benefit consultants advise when it comes to negotiating and performing both audits and market checks to reduce costs and get the most out of your PBM contract.***

As pharmacy benefit designs and drug pricing methodology become more complex, the margin for unintended error widens, often leaving employers or health plans responsible for a portion of their drug benefit they may not actually owe. To ensure that their PBMs are delivering rebates, pricing and other services in line with their contract terms, more plan sponsors are negotiating and exercising audit rights, from invoice review to complete performance evaluations.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: